RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml

CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807876
DOI: 10.1055/s-0045-1807876
NEUROENDOCRINE TUMORS
1976
POSTER PRESENTATION
Advanced therapeutic approaches in neuroendocrine tumors: from diagnosis to personalized therapy
Autoren
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Gabrielle Cardoso Ribas, Caroline Cavalcante Leite, Gabriela Lemos Andrade, Heitor Belinati Pereira Perez, Vitória Mosa Pulchério, Letícia Hanna Moura da Silva Gattas Graciolli, Lunara Gabriele Fernandes Barbosa, Amarílis de Oliveira Almeida, Evilym Pasquali Corbari, Sofia Dutra Morais, Cláudio Mariano da Silva, Isabela Santos de Marins, Letícia Batista de Carvalho, Maria Isabel Rocha de Menezes, Yasmin da Silva Moura. Advanced therapeutic approaches in neuroendocrine tumors: from diagnosis to personalized therapy. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807876
Gabrielle Cardoso Ribas, Caroline Cavalcante Leite, Gabriela Lemos Andrade, Heitor Belinati Pereira Perez, Vitória Mosa Pulchério, Letícia Hanna Moura da Silva Gattas Graciolli, Lunara Gabriele Fernandes Barbosa, Amarílis de Oliveira Almeida, Evilym Pasquali Corbari, Sofia Dutra Morais, Cláudio Mariano da Silva, Isabela Santos de Marins, Letícia Batista de Carvalho, Maria Isabel Rocha de Menezes, Yasmin da Silva Moura. Advanced therapeutic approaches in neuroendocrine tumors: from diagnosis to personalized therapy. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807876